These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 14253951)

  • 21. [8-PYRIDYLTHEOPHYLLINE: CHEMICAL AND PHARMACOLOGICAL RESEARCH].
    CASAGRANDE C; FERRARI G; BERGAMASCHI M; MARCHETTI G
    Boll Chim Farm; 1964 Sep; 103():641-52. PubMed ID: 14227286
    [No Abstract]   [Full Text] [Related]  

  • 22. [CONSIDERATIONS ON THE URINARY ELIMINATION OF 5-HYDROXYINDOLACETIC ACID IN CATTLE].
    BERTACCINI G; CHELI R
    Arch Sci Biol (Bologna); 1963; 47():336-8. PubMed ID: 14161382
    [No Abstract]   [Full Text] [Related]  

  • 23. EFFECTS OF PSYCHOTROPIC DRUG COMBINATIONS ON URINARY CONSTITUENTS IN THE DOG.
    PSCHEIDT GR; BRUNE GG; HIMWICH WA; HIMWICH HE
    J Neuropsychiatr; 1964 Dec; 5():502-8. PubMed ID: 14246550
    [No Abstract]   [Full Text] [Related]  

  • 24. [STUDY OF THE RATIO BETWEEN 17-HYDROXYCORTICOSTEROID AND 5-HYDROXYINDOLACETIC ACID EXCRETION IN PILOTS].
    FEDOROV IV; KHAZEN IM; STURUA GG
    Vopr Med Khim; 1963; 9():583-7. PubMed ID: 14150504
    [No Abstract]   [Full Text] [Related]  

  • 25. URINARY METABOLITES OF SOME MONOAMINES AND CLINICAL EFFECTS UNDER RESERPINE AND CHLORPROMAZINE.
    BOZZI R; BRUNO A; ALLEGRANZA A
    Br J Psychiatry; 1965 Feb; 111():176-82. PubMed ID: 14270530
    [No Abstract]   [Full Text] [Related]  

  • 26. [ELIMINATION OF THE PRINCIPAL URINARY METABOLITES OF SEROTONIN, DOPAMINE, NORADRENALINE, AND ADRENALINE DURING TREATMENT WITH RESERPINE AND WITH CHLOROPROMAZINE IN SCHIZOPHRENIC SUBJECTS. CLINICO-BIOLOGICAL CORRELATIONS].
    BRUNO A; BOZZI R; ALLEGRANZA A; DEVITO C
    Riv Patol Nerv Ment; 1963 Sep; 84():451-92. PubMed ID: 14153094
    [No Abstract]   [Full Text] [Related]  

  • 27. [CLINICAL STUDIES ON THE SECRETION OF INDOLEACETIC ACID IN URINE IN CHILDREN. II. UNDER VARIOUS CONDITIONS].
    ITO H
    Nihon Shonika Gakkai Zasshi; 1964 Oct; 68():914-9. PubMed ID: 14215019
    [No Abstract]   [Full Text] [Related]  

  • 28. [STUDY OF THE URINARY EXCRETION OF ENDOGENOUS 5-HYDROXYINDOLACETIC ACID IN MANIC-DEPRESSIVE PSYCHOSIS].
    ENKIN M; BECACHE A; REVOL L
    Encephale; 1963; 52():321-65. PubMed ID: 14079280
    [No Abstract]   [Full Text] [Related]  

  • 29. EXOGENOUS URINARY AMINES OF PLANT ORIGIN.
    PERRY TL; HANSEN S; HESTRIN M; MACINTYRE L
    Clin Chim Acta; 1965 Jan; 11():24-34. PubMed ID: 14287060
    [No Abstract]   [Full Text] [Related]  

  • 30. EFFECT OF DRUGS ON THE LEVELS OF INDOLE AND PHENOLIC ACIDS IN THE CENTRAL NERVOUS SYSTEM.
    ROOS BE; ANDEN NE; WERDINIUS B
    Int J Neuropharmacol; 1964 Apr; 3():117-22. PubMed ID: 14334586
    [No Abstract]   [Full Text] [Related]  

  • 31. [URINARY ELIMINATION OF 5-HYDROXYINDOLACETIC ACID, HOMOVANILLIC AND VANILLYLMANDELIC ACIDS IN SCHIZOPHRENIC SUBJECTS WITH RESERPINE AND CHLORPROMAZINE].
    ALLEGRANZA A; BOZZI R; BRUNO A
    Riv Patol Nerv Ment; 1963 Jun; 84():181-200. PubMed ID: 14088041
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the demonstration of 5-hydroxyindolacetic acid in the urine].
    SCHOEN H; ORDNUNG W; SCHMID E
    Klin Wochenschr; 1960 Apr; 38():405-6. PubMed ID: 14443329
    [No Abstract]   [Full Text] [Related]  

  • 33. FALSE POSITIVE REACTION DUE TO METHOCARBAMOL IN THE SCREENING TEST FOR VANILMANDELIC ACID (VMA).
    CAMPBELL DJ; SHERBANIUK R; RIGBY J
    Clin Chem; 1964 May; 10():447-50. PubMed ID: 14185803
    [No Abstract]   [Full Text] [Related]  

  • 34. [On normal values of hourly 5-hydroxyindolacetic acid in the urine in man and factors interrupting the measurements].
    DEGKWITZ R; FROWEIN R; KIRBERGER E; KULENKAMPFF C; MOHS U
    Klin Wochenschr; 1962 Mar; 40():285-9. PubMed ID: 13884858
    [No Abstract]   [Full Text] [Related]  

  • 35. [INFLUENCE OF THYROID ACTIVITY ON THE URINARY ELIMINATION OF 5-HYDROXYINDOLYLACETIC ACID IN THE RAT].
    GIORGINO R; DADDABBO A
    Folia Endocrinol; 1963 Dec; 16():699-708. PubMed ID: 14152435
    [No Abstract]   [Full Text] [Related]  

  • 36. THE RELATIONSHIP BETWEEN THE METABOLIC FATE AND PHARMACOLOGICAL ACTION OF 5-METHOXY-N-METHYLTRYPTAMINE.
    TABORSKY RG; MCISAAC WM
    Biochem Pharmacol; 1964 Mar; 13():531-4. PubMed ID: 14157616
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the level of 5-hydroxyindolacetic acid in urine in burns in children].
    KURZEPA S; LODZINSKI K
    Pediatr Pol; 1962 Jul; 37():693-701. PubMed ID: 14460855
    [No Abstract]   [Full Text] [Related]  

  • 38. [Urinary elimination of 5-hydroxyindolacetic acid in different aspects of human pathology].
    BARONI G; CIPRIANI D; SANTILLI E
    Osp Maggiore; 1962 Apr; 50():169-80. PubMed ID: 13865175
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the excretion of 5-hydroxyindolacetic acid in the urine in experimentally induced dumping syndrome].
    SCHMID E; MEYTHALER K; SCHOEN H; HENNING N
    Klin Wochenschr; 1962 Sep; 40():908-11. PubMed ID: 14498634
    [No Abstract]   [Full Text] [Related]  

  • 40. RELATIONSHIP BETWEEN URINARY EXCRETION-RATE OF 5-HYDROXYINDOLEACETIC ACID AND SURVIVAL-TIME OF X-IRRADIATED RATS.
    DEANOVIC Z; SUPEK Z
    Int J Radiat Biol Relat Stud Phys Chem Med; 1963 Dec; 7():569-74. PubMed ID: 14173282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.